Answer
Women of childbearing potential should use effective contraception throughout Poteligeo (mogamulizumab) treatment and for at least 6 months after treatment.
Sources for this answer
- Poteligeo 4 mg/mL, Concentrate for Solution for InfusionKyowa Kirin Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 8Document updated
Sources checked